Burning sensations, urgent urges, and the fear of the next recurrence: one in two women will experience a urinary tract infection during her lifetime, and 20 to 30% of them will have another one. Cranberry is the most studied natural remedy for preventing them. With what results, for whom, and at what dose?
This guide brings together what trials and the latest Cochrane review show: how cranberry works, in whom it reduces infections and in whom it performs no better than placebo, the dose of proanthocyanidins to target, capsules or juice, its place compared to D-mannose and antibiotics, precautions, and warning signs that require medical consultation.
What the studies show : in prevention, cranberry reduces the risk of urinary tract infection by approximately 30% according to the 2023 Cochrane review, which compiled 50 trials and nearly 9,000 participants. The benefit is clear in women prone to cystitis, with approximately 26% fewer recurrences, in children and after medical procedures, where the risk is nearly cut in half. It is not demonstrated during pregnancy, in elderly people in care facilities, or for treating an already established infection.
How to take it : it is type A proanthocyanidins, or PAC, that prevent E. coli from adhering to the bladder wall. Positive trials target 36 mg of PAC per day, measured by the DMAC method, and their effect wears off within 24 hours: one dose each day, ideally divided between morning and evening, for at least 12 to 24 weeks. Fever, back pain, blood in urine, or symptoms in a man, pregnant woman, or child require medical consultation.
- How cranberry works: type A PACs
- What the 2023 Cochrane review shows
- Recurrent cystitis in women
- Children, surgery, pregnancy, elderly people
- Does it treat an ongoing infection?
- Capsules or juice: the dosage that matters
- Cranberry, D-mannose or antibiotic?
- Side effects, interactions and precautions
- The anti-recurrence plan
- Frequently asked questions
How cranberry works: type A PAC
To infect the bladder, the bacterium Escherichia coli, the most common culprit, must first adhere to its wall thanks to fine filaments called fimbriae. This is the step that cranberry targets: its type A proanthocyanidins, or PAC, prevent adhesion of uropathogenic E. coli strains equipped with P fimbriae. The bacterium, unable to attach, is then eliminated through urine.
Researchers compared cranberry proanthocyanidins to those from grapes, apples, green tea, and chocolate. Only cranberry's type A proanthocyanidins blocked E. coli adhesion at low concentration; those from grapes, type B, worked only at twenty times higher concentration, and the others not at all. After consumption, only the urine of volunteers who took cranberry prevented bacterial adhesion.
Howell AB, Reed JD, Krueger CG, et al. Phytochemistry 2005;66(18):2281-2291. DOI: 10.1016/j.phytochem.2005.05.022
This effect depends on dose and does not last. In a trial with 32 women, urine collected 1 to 6 hours after intake blocked bacterial adhesion in 50% of cases with 18 mg PAC, 90.6% with 36 mg, and 100% with 72 mg. Twenty-four hours later, activity had disappeared at 18 mg and persisted in only 12.5% of cases at 36 mg, and 50% at 72 mg. The authors conclude that 36 mg per day is effective, and suggest two doses to cover the day.
Cranberry acts in prevention, continuously: it must be present in urine when bacteria attempt to establish themselves. Hence a dose every day, ideally split between morning and evening. And hence a limitation: once infection is established, preventing adhesion is no longer sufficient.
What the 2023 Cochrane review shows
The Cochrane review is the reference in evidence-based medicine. Its 2023 update brings together 50 randomized trials and 8,857 participants. It reverses the conclusion of its 2012 version, which found no effect: with more trials, cranberry reduces the risk of urinary tract infection by approximately 30%, with certainty judged as moderate.
| Population | Effect on risk | Certainty |
|---|---|---|
| All participants | −30% (RR 0.70) | Moderate |
| Women prone to cystitis | −26% (RR 0.74) | Moderate |
| Children | −54% (RR 0.46) | Moderate |
| After a medical intervention | −53 % (RR 0.47) | Moderate |
| Elderly people in residential care facilities | No net effect (RR 0.93) | Moderate |
| Pregnancy | No net effect (RR 1.06) | Moderate |
| Neurogenic bladder | No net effect (RR 0.97) | Low |
The message is therefore nuanced. Cranberry is beneficial for women prone to cystitis, in children, and after surgery, medical intervention, urinary catheterization, or radiotherapy. It has not proven its value in elderly people living in care facilities, during pregnancy, or in cases of neurogenic bladder. The authors also emphasize that the products tested were heterogeneous, and that their PAC content was often not indicated.
A 2017 meta-analysis, limited to healthy women susceptible to recurrence, reached the same figure: 7 trials, 1,498 women, and 26% fewer recurrences.
Recurrent cystitis in women
Recurrent cystitis is defined as two or more episodes in six months, or three or more in one year. This is the most studied situation, and the one where cranberry has the most practical value.
Three hundred seventy-three women with a recent urinary tract infection drank 240 mL daily of a cranberry beverage or placebo for 24 weeks. The cranberry group had 39 clinical urinary tract infections, compared to 67 under placebo, representing 39% fewer episodes: one episode prevented for every 3.2 woman-years of treatment.
Maki KC, Kaspar KL, Khoo C, et al. Am J Clin Nutr 2016;103(6):1434-1442. DOI: 10.3945/ajcn.116.130542
A caveat accompanies this result: infections confirmed by urine culture did not decrease significantly. Other trials point in the same direction. A whole fruit powder taken at 500 mg per day for 6 months in 182 women reduced the proportion of infected women from 25.8% under placebo to 10.8%. A 2012 trial with juice in 176 women found a favorable, but not statistically significant trend.
Does the PAC dose matter? A 2021 trial compared two doses of a standardized extract in 145 women: 2 × 18.5 mg and 2 × 1 mg of PAC per day for 24 weeks. The higher dose reduced infections by 24%, a non-significant difference, and extended the median time without infection from 16.6 to 24 weeks. In a secondary analysis, in women with fewer than five infections per year, the reduction reached 43%. The only side effect noted was digestive discomfort.
Overall, in women prone to cystitis, cranberry reduces recurrences by approximately one quarter: a modest benefit, but achieved without antibiotics. Our guide to recurrent cystitis details the causes and other preventive measures.
Children, surgery, pregnancy, elderly people
Inchildren, the Cochrane review estimates, based on 504 children, that cranberry reduces the risk of urinary tract infection by more than half. It is then given on medical advice, as a urinary tract infection in children always warrants a medical consultation.
One hundred sixty women undergoing gynecological surgery with urinary catheter placement took two cranberry capsules or placebo twice daily for 6 weeks. A urinary tract infection occurred in 19% of those receiving cranberry, compared to 38% receiving placebo. Digestive disturbances were equally frequent in both groups, 56% and 61%.
Foxman B, Cronenwett AE, Spino C, et al. Am J Obstet Gynecol 2015;213(2):194.e1-194.e8. DOI: 10.1016/j.ajog.2015.04.003
The result is not uniform: after pelvic floor surgery, a trial in 210 women found no significant difference, 12.4% versus 20%, with infections less frequent than expected in both groups. Across all trials, the Cochrane review reports a 53% reduction in risk following an intervention.
During pregnancy, cranberry did not reduce urinary tract infections in trials. It does not appear to be harmful: in a Norwegian cohort of 68,522 women, the 919 who had consumed it during pregnancy did not have more birth defects, premature births, or low birth weights. A urinary tract infection in pregnant women requires medical treatment.
In elderly elderly people living in care facilities, the effect is not demonstrated. In a one-year trial involving 185 women with an average age of 86, capsules providing 72 mg of PAC per day did not reduce the presence of bacteria and white blood cells in the urine, 29.1% versus 29% under placebo, and symptomatic infections remained rare in both groups, 10 versus 12. Inmen, finally, no dedicated trial was found: any urinary tract infection in men warrants medical advice.
Does it treat an ongoing infection?
Three trials, 688 participants, tested cranberry to treat acute uncomplicated urinary tract infection. Cranberry juice did not relieve symptoms better than water and did not reduce antibiotic use; when added to an antibiotic, it provided no benefit. The authors judge the evidence insufficient to recommend cranberry for this indication.
Gbinigie OA, Spencer EA, Heneghan CJ, et al. Antibiotics (Basel) 2020;10(1):12. DOI: 10.3390/antibiotics10010012
An untreated cystitis is not benign: according to data cited by a review of international recommendations, 5% progress to a kidney infection, pyelonephritis, within 6 weeks. Drinking more water, on the other hand, helps prevent recurrences: in these same data, increasing water intake reduced the risk by more than half.
Fever, pain in the lower back or on the side, which may signal a kidney infection; blood in the urine; urinary tract infection in a man, pregnant woman, or child; no improvement within 48 hours; at least two cystitis episodes in six months or three in one year. In these situations, the recommendations provide for medical advice, and often an antibiotic.
Capsules or juice: the dosage that matters
The figure to look at is the quantity of proanthocyanidins (PAC) per day. A 2024 meta-analysis covering 10 trials that specified this dose, involving 2,438 participants, finds a benefit starting from 36 mg of PAC per day, with 18% fewer infections, and no significant effect below that. The benefit appeared especially for durations of 12 to 24 weeks, with 25% fewer infections.
Still, the content must be measured correctly. The authors designate as reference the DMACmethod, calibrated on procyanidin A2, with other methods overestimating the PAC content. A 2026 study conducted by four laboratories on 53 supplements sold in the United States demonstrates the issue: only 3 achieved 36 mg of PAC per day at the recommended dose, and those displaying a certain content contained less than declared.
| Form | Studied dose | Result |
|---|---|---|
| Juice, 240 mL per day | Approximately 41 mg of PAC | 39% fewer clinical infections over 24 weeks |
| Standardized extract in capsules | 2 × 18.5 mg of PAC | −24%, not significant, against a very low dose |
| Whole fruit powder | 500 mg, i.e. 2.8 mg of PAC | 10.8% versus 25.8% of infected women over 6 months |
| Capsules after surgery | 2 capsules twice daily | 19% versus 38% infections |
| Capsules, very elderly women | 72 mg of PAC | No effect |
This table also shows the limitations of this criterion: a whole fruit powder with low PAC content gave a positive result, and the Cochrane review found no clear difference between doses. PACs remain nonetheless the best available reference point, as they carry the best-established mechanism.
Juice or capsules? A 2024 network meta-analysis associates juice with 27% fewer infections compared to a placebo beverage, but the Cochrane review does not differentiate between forms. Juice provides sugars, which warrants caution in cases of diabetes; approximately 300 mL of cocktail juice is needed to provide 36 mg of PACs. Capsules avoid this sugar and are easy to take daily.
Look for the amount of PACs in mg per daily dose, the dosing method, DMAC or BL-DMAC, and the reference standard, procyanidin A2. The weight of extract alone provides little information: in trials, 240 mg of extract provided 37 mg of PACs, while 500 mg of fruit powder provided only 2.8 mg.
Regarding timing, the anti-adhesion activity peaks 1 to 6 hours after intake and drops within 24 hours: cranberry should be taken daily, ideally in two doses, morning and evening. Trials lasted from 6 weeks after surgery to 24 weeks for recurrent cystitis, and up to one year.
Cranberry, D-mannose, or antibiotic?
Two hundred twenty-one non-menopausal women prone to cystitis took either cranberry capsules, 500 mg twice daily, or a preventive antibiotic, trimethoprim-sulfamethoxazole, for 12 months. The antibiotic better prevented infections, 1.8 per year versus 4.0 with cranberry. But after one month, 86.3% of E. coli in the intestinal flora were resistant to it, compared to 23.7% with cranberry.
Beerepoot MA, ter Riet G, Nys S, et al. Arch Intern Med 2011;171(14):1270-1278. DOI: 10.1001/archinternmed.2011.306
Across all trials comparing cranberry and preventive antibiotic, the Cochrane review finds little difference in efficacy. The choice should be discussed with your doctor: the antibiotic provided better protection in this trial, cranberry spares the flora and promotes far fewer resistances.
<<<17>>> D-mannose D-mannose, a simple sugar, is often presented as an alternative. An initial 2014 trial in 308 women was encouraging: 14.6% recurrence with 2 g daily, versus 20.4% with nitrofurantoin and 60.8% without treatment. But a large double-blind trial published in 2024, in 598 women followed in general practice, did not confirm this: 51% of women on D-mannose consulted for a urinary infection within 6 months, compared to 55.7% on placebo, a non-significant difference. No trial directly compares D-mannose and cranberry.
| Option | What the trials show | To note |
|---|---|---|
| Cranberry | −26% recurrence in women prone to cystitis | Daily intake; PAC content to be verified |
| Preventive antibiotic | 1.8 infections per year, versus 4.0 with cranberry | 86% of intestinal E. coli resistant after one month |
| D-mannose | No better than placebo in the largest trial | A previous favorable trial, not confirmed |
| Drink more | Risk of recurrence reduced by more than half | Data cited by a review of recommendations |
Side effects, interactions, and precautions
Cranberry is well tolerated. In the Cochrane review, digestive disorders, particularly abdominal pain, are somewhat more frequent than with placebo, on the order of one third more. With capsules, they were as frequent as with placebo in the post-surgery trial, 56% versus 61%; with juice, minor effects were reported by 24.2% of women, versus 12.5% on placebo.
Anticoagulants : a 2010 review examined 15 reported cases and 7 trials; only 2 cases were considered probable, and the trials showed no interaction with moderate juice consumption. But in 12 healthy men, two weeks of cranberry increased warfarin's anticoagulant effect by 30%, and one patient's INR rose to 6.5 after drinking nearly 2 liters of juice daily. With anticoagulants, medical advice and INR monitoring are required before taking it.
Kidney stones : in 5 volunteers, cranberry tablets increased urinary oxalate by 43.4% in one week, and one liter of juice daily increased calcium oxalate saturation by 18% in 24 adults. A third study, with 500 mL of juice daily, showed conversely a decrease in oxalate. As a precaution, if there is a history of calcium oxalate stones, it is better to discuss this with your doctor.
| Situation | What the data shows | Approach |
|---|---|---|
| Anticoagulant | No interaction demonstrated with moderate juice amounts; increases in INR described | Medical advice and INR monitoring |
| Calcium oxalate stones | Urinary oxalate increased in two out of three studies | Medical advice |
| Diabetes | Juice contains sugars | Prefer a sugar-free form |
| Pregnancy | No additional birth defects; no demonstrated benefit | Infection treated by a doctor |
| Ongoing infection | No demonstrated effect on symptoms | Consult your doctor |
The recurrence prevention plan
International guidelines assign cranberry a variable role: the European Association of Urology does not take a position, British and American guidelines recommend it with weak level of evidence, the Canadian Society of Obstetricians and Gynaecologists strongly recommends it. These guidelines predate the 2023 Cochrane update, which is more favorable to cranberry.
An organic cranberry extract (Vaccinium macrocarpon), rich in type A proanthocyanidins, in vegetable capsules manufactured in France. Two capsules per day, or 1 g of extract, to be taken during meals, preferably one in the morning and one in the evening, to support long-term prevention.
See CranberryOur guide to recurrent cystitis details other studied active ingredients.
Frequently Asked Questions
Is cranberry effective against urinary tract infection?
For prevention, yes: according to the 2023 Cochrane review, it reduces the risk of urinary tract infection by approximately 30%, and recurrence by approximately 26% in women prone to cystitis. The effect is more pronounced in children and after medical procedures, where the risk is nearly halved. It has not been demonstrated during pregnancy or in elderly people in care facilities.
Does cranberry cure an already declared cystitis?
This is not demonstrated: in trials, cranberry juice did not relieve symptoms better than water and did not reduce antibiotic use. An active infection warrants medical advice, especially in case of fever, lower back pain, or blood in the urine.
What is the dosage for cranberry capsules?
The benchmark from trials is 36 mg of proanthocyanidins (PAC) per day, measured by the DMAC method; 72 mg maintains partial activity over 24 hours. Since the effect wanes within 24 hours, intake is daily, ideally split between morning and evening. Extract weight alone is insufficient to judge a product.
Cranberry juice or capsules: which to choose?
Both forms have been studied and the Cochrane review does not distinguish between them. Juice provides sugars, which warrants caution in case of diabetes; capsules avoid this sugar, provided their PAC content is known.
How long should you take cranberry?
Trials range from 6 weeks after surgery to 24 weeks for recurrent cystitis, and up to one year. The benefit appears mainly between 12 and 24 weeks of regular use.
Cranberry or D-mannose?
No trial compares them directly. D-mannose, at 2 g per day, did not perform better than placebo in 598 women in the largest trial, despite a previous favorable trial. Cranberry has a favorable Cochrane review in women prone to cystitis.
Can cranberry replace preventive antibiotics?
In a one-year trial, antibiotics prevented more cystitis cases, 1.8 versus 4.0 per year, but after one month 86% of intestinal E. coli were resistant to it, compared to 24% with cranberry. The choice should be discussed with your doctor.
Is cranberry useful during pregnancy?
It did not reduce urinary tract infections during pregnancy in trials. In a cohort of 68,522 women, its consumption was not associated with more birth defects. A urinary tract infection in pregnant women should be treated medically.
What precautions should be taken with cranberry?
If on anticoagulants, seek medical advice: trials show no interaction with moderate juice consumption, but increases in INR have been reported. In case of calcium oxalate stones, use caution: urinary oxalate increased in two out of three studies. Digestive disturbances are slightly more frequent than with placebo.
When should you consult for a urinary tract infection?
In case of fever, lower back pain, or blood in the urine; in a man, pregnant woman, or child; if no improvement within 48 hours; or after at least two cases of cystitis in six months or three in one year.
Sources
The studies cited below were identified via PubMed.
- Williams G, Stothart CI, Hahn D, et al. Cranberry for the prevention of urinary tract infections. Cochrane Database of Systematic Reviews, 2023;11(11):CD001321. DOI
- Fu Z, Liska D, Talan D, Chung M. Cranberry reduces the risk of recurrent urinary tract infection in healthy women: systematic review and meta-analysis. Journal of Nutrition, 2017;147(12):2282-2288. DOI
- Xiong Z, Gao Y, Yuan C, et al. Preventive effect of high-dose proanthocyanidin cranberry on urinary tract infections: meta-analysis and systematic review. Frontiers in Nutrition, 2024;11:1422121. DOI
- Moro C, Phelps C, Veer V, et al. Cranberry juice, cranberry tablets or beverages versus urinary tract infections: a systematic review and network meta-analysis. European Urology Focus, 2024;10(6):947-957. DOI
- Howell AB, Reed JD, Krueger CG, et al. Type A proanthocyanidins of cranberry and anti-adhesion activity against uropathogenic bacteria. Phytochemistry, 2005;66(18):2281-2291. DOI
- Howell AB, Botto H, Combescure C, et al. Dose effect on urinary anti-adhesion activity against E. coli following consumption of a proanthocyanidin-standardized cranberry powder: a multicenter randomized double-blind study. BMC Infectious Diseases, 2010;10:94. DOI
- Maki KC, Kaspar KL, Khoo C, et al. A cranberry beverage reduced the number of clinical urinary tract infections in women with a recent history of urinary tract infection. American Journal of Clinical Nutrition, 2016;103(6):1434-1442. DOI
- Vostalova J, Vidlar A, Simanek V, et al. Is high proanthocyanidin content the key to cranberry effectiveness against recurrent urinary tract infections? Phytotherapy Research, 2015;29(10):1559-1567. DOI
- Stapleton AE, Dziura J, Hooton TM, et al. Recurrent urinary tract infections and urinary E. coli in women drinking cranberry juice daily: a randomized controlled trial. Mayo Clinic Proceedings, 2012;87(2):143-150. DOI
- Babar A, Moore L, Leblanc V, et al. High or low dose standardized cranberry proanthocyanidin extract to prevent recurrent urinary tract infections in women: a double-blind randomized controlled trial. BMC Urology, 2021;21(1):44. DOI
- Foxman B, Cronenwett AE, Spino C, et al. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized controlled trial. American Journal of Obstetrics and Gynecology, 2015;213(2):194.e1-194.e8. DOI
- Mooren ES, Liefers WJ, de Leeuw JW. Cranberry after pelvic floor surgery to prevent urinary tract infections: a randomized controlled trial. Neurourology and Urodynamics, 2020;39(5):1543-1549. DOI
- Juthani-Mehta M, Van Ness PH, Bianco L, et al. Effect of cranberry capsules on bacteriuria with pyuria in elderly women in nursing homes: a randomized controlled trial. JAMA, 2016;316(18):1879-1887. DOI
- Heitmann K, Nordeng H, Holst L. Pregnancy outcome after cranberry consumption during pregnancy: the Norwegian Mother and Child Cohort Study. BMC Complementary and Alternative Medicine, 2013;13:345. DOI
- Gbinigie OA, Spencer EA, Heneghan CJ, et al. Cranberry extract for symptoms of acute uncomplicated urinary tract infection: a systematic review. Antibiotics, 2020;10(1):12. DOI
- Kwok M, McGeorge S, Mayer-Coverdale J, et al. Recommendations for the management of recurrent urinary tract infections in women: a comparative review. BJU International, 2022;130 Suppl 3:11-22. DOI
- Beerepoot MA, ter Riet G, Nys S, et al. Cranberry versus antibiotics to prevent urinary tract infections: a randomized double-blind non-inferiority trial in non-menopausal women. Archives of Internal Medicine, 2011;171(14):1270-1278. DOI
- Hayward G, Mort S, Hay AD, et al. D-mannose to prevent recurrent urinary tract infections in women: a randomized trial. JAMA Internal Medicine, 2024;184(6):619-628. DOI
- Kranjčec B, Papeš D, Altarac S. D-mannose powder to prevent recurrent urinary tract infections in women: a randomized trial. World Journal of Urology, 2014;32(1):79-84. DOI
- Pandey D, Vavilala S, Gusev P, et al. Measured proanthocyanidin content of cranberry supplements and comparison with declared contents: a multi-laboratory study using the DMAC method. Journal of Nutrition, 2026;156(7):101582. DOI
- Zikria J, Goldman R, Ansell J. Cranberry juice and warfarin: when bad reputation outweighs science. American Journal of Medicine, 2010;123(5):384-392. DOI
- Mohammed Abdul MI, Jiang X, Williams KM, et al. Pharmacodynamic interaction of warfarin with cranberry, but not garlic, in healthy subjects. British Journal of Pharmacology, 2008;154(8):1691-1700. DOI
- Hamann GL, Campbell JD, George CM. Interaction between warfarin and cranberry juice. Annals of Pharmacotherapy, 2011;45(3):e17. DOI
- Terris MK, Issa MM, Tacker JR. Cranberry concentrate tablet supplementation could increase the risk of kidney stones. Urology, 2001;57(1):26-29. DOI
- Gettman MT, Ogan K, Brinkley LJ, et al. Effect of cranberry juice consumption on urinary stone risk factors. Journal of Urology, 2005;174(2):590-594. DOI
- McHarg T, Rodgers A, Charlton K. Influence of cranberry juice on urinary risk factors for calcium oxalate stones. BJU International, 2003;92(7):765-768. DOI
